MAY 20, 2017 10:46 AM PDT

Scientists Exploit Zika to Kill Brain Cancer

WRITTEN BY: Xuan Pham

Zika was a relatively an unknown name in the Americas until around 2015 when the outbreak in Brazil caught the world’s attention. The virus is known to cause severe birth defects in the developing fetus. But while much attention has been devoted to understanding and preventing Zika transmission, researchers at the University of Cambridge see a golden opportunity in Zika as a way to fight against deadly brain cancers.

Image credit: wikipedia.org

“Zika virus infection in babies and children is a major global health concern, and the focus has been to discover more about the virus to find new possible treatments,” said Dr. Harry Bulstrode, a Cancer Research UK scientist at Cambridge. “We’re taking a different approach, and want to use these new insights to see if the virus can be unleashed against one of the hardest to treat cancers.”

In particular, Bulstrode and his team are fascinated by Zika’s ability to cross the blood-brain barrier, an elusive feat that most drugs can’t achieve. Indeed, Johns Hopkins researchers were among the first to prove that the Zika virus is capable of crossing both the placental barrier and the blood-brain barrier. Furthermore, in the brain, the virus targets cortical neural progenitor cells to make more of the virus. This is one of the mechanisms behind the microcephaly birth defects seen in babies born to Zika-infected mothers.

But while the virus wreaks havoc in the developing fetal brain, the virus usually doesn’t do much in the adult brain. And these attributes can be exploited to treat glioblastomas, the most common and deadly form of primary brain cancer.

Bulstrode and his team see the virus as effective glioblastomas killers, as the cancer cells may be similar to the stem cells that the virus attacks in the fetal brain. The potential is huge, and Bulstrode’s team has been awarded with a sizeable grant to test this in cell and animal models. Their goal will be to show whether Zika can selectively target glioblastoma cells without harming nearby healthy tissues.

“We hope to show that the Zika virus can slow down brain tumour growth in tests in the lab.  If we can learn lessons from Zika’s ability to cross the blood-brain barrier and target brain stem cells selectively, we could be holding the key to future treatments,” said Bulstrode.

“We urgently need new insights and treatments to tackle glioblastomas, one of the most common and difficult to treat forms of brain tumours,” said Dr. Iain Foulkes, director of research and innovation at Cancer Research UK. “Finding new ways to treat brain tumours to help more people survive the disease is a priority for Cancer Research UK. Dr Bulstrode’s research is an incredibly innovative way to expand our understanding of how we can beat this disease, which remains a notorious challenge.

Additional source: Cancer Research UK

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 31, 2018
Cancer
JUL 31, 2018
Protein Regulation of DNA Replication in Cancer Cells - A New Early Target for Broad Therapeutics?
DNA replication is a carefully regulated process in each cell of the body. Researchers are looking at the mechanism of DNA replication and associated proteins as a therapy target in cancer...
AUG 10, 2018
Immunology
AUG 10, 2018
Cancer Cell 'Drones' Battle Immune System
Cancer cells release PD-L1 containing exosomes that circulate in the blood and stop T cells before they can reach tumors....
NOV 14, 2018
Immunology
NOV 14, 2018
Rapid Tumor Targeting
Researchers at the University of California Irvine have developed a technology that will rapidly identify and target T cell receptors for tumor specific antigens...
NOV 14, 2018
Immunology
NOV 14, 2018
Reversing T Cell dysfunction in Cancer: Getting the Body to Fight its own Battles
Using the power of the immune system to eliminate cancerous cells has long the been the goal of immuno-oncology. Immune cells naturally recognize, destroy,...
DEC 04, 2018
Drug Discovery
DEC 04, 2018
Drug Combination May Be Effective for Melanoma
Protein kinase inhibitors have been noted to be the most effective class of drugs in the treatment of melanoma—a deadly skin cancer of the melanocyte...
DEC 06, 2018
Microbiology
DEC 06, 2018
A Bacterial Protein can Encourage Cancer Development
It's been suggested that a fifth of all cancers are caused by microbial infections, and new work indicates that the estimate is probably low....
Loading Comments...